Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Active Ingredients: Human Papillomavirus (HPV) 11 L1 Protein 80µg/mL
Human Papillomavirus (HPV) 16 L1 Protein 80µg/mL
Human Papillomavirus (HPV) 18 L1 Protein 40µg/mL
Human Papillomavirus (HPV) 6 L1 Protein 40µg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck & Co Inc, West Point, Pennsylvania, United States of America
Merck Sharp & Dohme BV, Haarlem, The Netherlands
Active Ingredient: Bortezomib 3.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Dated this 22nd day of May 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).